Bookmark

Add to MyYahoo RSS

Hemophilia News

News on Hemophilia continually updated from thousands of sources around the net.

7 hrs ago | Hispanic Business

Baxter Reports Strong First Quarter Financial Results Exceeding...

For the first quarter, Baxter reported net income of per diluted share), for intangible asset amortization and costs associated with the integration of its Gambro AB acquisition, business development and business optimization initiatives.

Comment?

Related Topix: Medicine, Baxter International, Medical Equipment, Healthcare Industry

Wed Apr 16, 2014

Investopedia

3 Stocks To Profit From The Gene Therapy Revolution

Britain's Queen Victoria left an unfortunate legacy: Her descendants, spread across numerous European royal families, all inherited a genetic mutation that causes hemophilia.

Comment?

Related Topix: Genetics, Medicine, Baxter International, Medical Equipment, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration

US Food and Drug Administration

Hemophilia Treatments Have Come a Long Way

Gone are the days when a hemophilia diagnosis meant you could not live a normal life.

Comment?

Related Topix: Health, Food and Drug Administration

Sys-Con Media

PharmaPoint: Hemophilia A and B - US Drug Forecast and Market Analysis to 2022

However, the burden on patients and their families to maintain the prophylactic treatment schedule is high, and there is a significant unmet need for new therapies that can reduce the number of weekly prophylactic infusions and alleviate some of this treatment burden.

Comment?

Related Topix: Health, Medicine, Kogenate, Antihemophilic Factor (generic)

Freshnews

Baxter Meets Primary Efficacy Endpoint in Phase 3 Trial of BAX 111,...

Baxter International Inc. today announced topline results from a Phase 3 clinical trial evaluating the safety, efficacy and pharmacokinetics of BAX 111.

Comment?

Related Topix: Medicine, Baxter International, Medical Equipment, Healthcare Industry, Pharmacology, Food and Drug Administration, Health

Hispanic Business

Baxter to Acquire Chatham Therapeutics

According to a release, as a result of the transaction, Baxter will acquire Chatham's developmental gene therapy programs directed toward the development and commercialization of treatments for hemophilia.

Comment?

Related Topix: Health, Science / Technology, Nanotechnology

Tue Apr 15, 2014

Seeking Alpha

Is Biogen A Value Stock Yet?

Biogen Idec may be headquartered in Cambridge, Massachusetts, but it still has many ties to my hometown of San Diego.

Comment?

Related Topix: Biotech, Biogen Idec, Cambridge, MA, Science / Technology, Isis Pharmaceuticals, Medicine, Healthcare Industry, Health, Multiple Sclerosis

Mon Apr 14, 2014

PR-inside.com

Hemophilia A - Pipeline Review, H2 2013 - new market research report published

This report provides information on the therapeutic development for Hemophilia A, complete with latest updates, and special features on late-stage and discontinued projects.

Comment?

Related Topix: Health

BroadwayWorld.com

Coeurage Theatre Partners with Hemophilia Foundation, Elizabeth...

Coeurage Theatre Company , LA's 'Pay What You Want' Company, has announced it will share a portion of box office proceeds from their production of The Yellow Boat with the Hemophilia Foundation of Southern California and the Elizabeth Glaser Pediatric AIDS Foundation.

Comment?

Related Topix: Health, HIV/AIDS, California, Family, Kids

Sun Apr 13, 2014

BayStreet.ca

JPMorgan Chase First Quarter Earnings Falls 20 Percent; FBI Probes...

JPMorgan Chase & Co. - For an in-depth report on JPMorgan Chase & Co. follow: www.BullTrends.com/stockquote/JPM Shares of JPMorgan closed down 3.66% on about 47.2 million shares traded.

Comment?

Related Topix: Banking, JP Morgan Chase , Biotech, Biogen Idec, Health, Canadian Solar

Thu Apr 10, 2014

ASHP

New Treatment for Hemophilia B Involves Less-Frequent Injections

FDA and Biogen Idec on March 28 announced the approval of recombinant factor IX Fc fusion protein, or Alprolix, for use in patients with hemophilia B. The prolonged circulating half-life of the fusion protein allows patients with hemophilia B to go at least one week between routine prophylactic injections, according to the new product's labeling .

Comment?

Related Topix: Health, Biotech, Biogen Idec

Reuters

Biogen's blood disorder drug succeeds in late-stage trial

Biogen Idec Inc and Swedish Orphan Biovitrum said their experimental blood disorder drug was effective in treating children with hemophilia in a late-stage trial.

Comment?

Related Topix: Healthcare Law, Law, Health, Food and Drug Administration

Gawker

Who Has More Hair, Prince George or Prince William? An Investigation

Prince William and his son Prince George have many things in common: a patriotic duty to the nation of their birth; an intimate working knowledge of Kate Middleton's breasts; a high risk of hemophilia.

Comment?

Related Topix: Prince William, World News, Health

Wed Apr 09, 2014

Hispanic Business

Erasing a genetic mutation

The findings, described in the issue of Nature Biotechnology, offer the first evidence that this gene-editing technique, known as CRISPR, can reverse disease symptoms in living animals.

Comment?

Related Topix: Genetics, Medicine, Health

Tue Apr 08, 2014

Hispanic Business

Baxter to Purchase Chatham Therapeutics

According to a release, as a result of the transaction, Baxter will acquire Chatham's developmental gene therapy programs directed toward the development and commercialization of treatments for hemophilia.

Comment?

Related Topix: Health, Science / Technology, Nanotechnology

Fri Apr 04, 2014

Boston.com

Biogen Idec chief warns against funding cuts

The top executive of Biogen Idec Inc. said Thursday that the state's drug makers are producing breakthrough treatments for conditions ranging from multiple sclerosis to hepatitis C to hemophilia.

Comment?

Related Topix: Biotech, Biogen Idec, Medicine, Science / Technology, Genzyme General, Healthcare Industry, Cambridge, MA

Thu Apr 03, 2014

California Computer News

Gene-Editing Method Cures Mice of a Disease

Using a new gene-editing system based on bacterial proteins, MIT researchers have cured mice of a rare liver disorder caused by a single genetic mutation.

Comment?

Related Topix: Genetics, Medicine, Health

Cape Cod Times

Small Doses

The Food and Drug Administration has approved the first hemophilia B treatment designed to decrease frequency of injections to prevent the excessive bleeding the clotting disorder causes.

Comment?

Related Topix: Health, Cambridge, MA, Genetics, Medicine

Wed Apr 02, 2014

Freshnews

Alnylam to Webcast Presentation at 13th Annual Needham Healthcare Conference

Alnylam Pharmaceuticals, Inc . , a leading RNAi therapeutics company, today announced that management will present a company overview at the 13th Annual Needham Healthcare Conference on Wednesday, April 9, 2014 at 12:50 p.m. ET at the Westin Grand Central Hotel in New York City.

Comment?

Related Topix: Biotech, Medicine, Sirna Therapeutics, Healthcare Industry, Alnylam Pharmaceuticals, Genetics, Health

Freshnews

Baxter to Acquire Chatham Therapeutics

DEERFIELD, Ill. & CHAPEL HILL, N.C. -- -- Baxter International Inc. and Chatham Therapeutics, LLC, today announced that Baxter has agreed to acquire all of Chatham's outstanding membership interests.

Comment?

Related Topix: Medicine, Baxter International, Medical Equipment, Healthcare Industry, Chapel Hill, NC, Health, Science / Technology, Nanotechnology, Marketing

•••
•••
•••
•••
•••
•••
•••
•••
•••